AVITA Medical annual return on equity
2018
2019
2020
2021
2021
2022
2023
2024
AVITA Medical Return on Equity (ROE) Growth & History (RCEL)
AVITA Medical's return on equity was −230.96% for fiscal 2024.
View full AVITA Medical company overviewAVITA Medical annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −230.96% | −178.07 pp |
| 2023 | 2023-12-31 | −52.89% | −24.73 pp |
| 2022 | 2022-12-31 | −28.16% | −15.06 pp |
| 2021 · Dec 31 | 2021-12-31 | −13.10% | — |
| 2021 · Jun 30 | 2021-06-30 | −28.27% | +61.89 pp |
| 2020 | 2020-06-30 | −90.16% | +53.84 pp |
| 2019 | 2019-06-30 | −144.00% | −2.19 pp |
| 2018 | 2018-06-30 | −141.81% | — |
AVITA Medical quarterly return on equity
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2024 | 2024-12-31 | −138.57% | −125.96 pp |
| Q3 2024 | 2024-09-30 | −89.67% | −76.44 pp |
| Q2 2024 | 2024-06-30 | −54.50% | −40.30 pp |
| Q1 2024 | 2024-03-31 | −45.72% | −34.35 pp |
| Q4 2023 | 2023-12-31 | −12.61% | −6.41 pp |
| Q3 2023 | 2023-09-30 | −13.24% | −7.05 pp |
| Q2 2023 | 2023-06-30 | −14.20% | −7.63 pp |
| Q1 2023 | 2023-03-31 | −11.36% | −2.01 pp |
| Q4 2022 | 2022-12-31 | −6.20% | −8.27 pp |
| Q3 2022 | 2022-09-30 | −6.19% | −0.95 pp |
| Q2 2022 | 2022-06-30 | −6.58% | −2.56 pp |
| Q1 2022 · Mar 31 | 2022-03-31 | −9.35% | −2.63 pp |
| Q4 2021 | 2021-12-31 | 2.07% | +11.09 pp |
| Q1 2022 · Sep 30 | 2021-09-30 | −5.24% | +9.60 pp |
| Q4 2021 | 2021-06-30 | −4.02% | +23.68 pp |
| Q3 2021 | 2021-03-31 | −6.72% | — |
| Q2 2021 | 2020-12-31 | −9.02% | — |
| Q1 2021 | 2020-09-30 | −14.83% | — |
| Q4 2020 | 2020-06-30 | −27.70% | — |
AVITA Medical return on equity trends
Between the periods ended 2018-06-30 and 2024-12-31, AVITA Medical's return on equity decreased from −141.81% to −230.96%, a change of −89.15 percentage points. The latest reported quarter, Q4 2024, shows −138.57%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AVITA Medical source filings ↗